1. Cancer Genetics Moves out of Its Winter of Discontent

   • Kevin S. Hughes
   • Kanhua Yin

   ASO Perspectives 10 June 2022 Pages: 5341 - 5343

2. Neoadjuvant Immunotherapy for Resectable Non-small Cell Lung Cancer: Exciting New Horizon in Early-Stage Lung Cancer Care

   • Jessica S. Donington

   ASO Perspectives 27 May 2022 Pages: 5344 - 5346

3. Complementary Roles of Screening and Nodule Programs for Early Detection of Lung Cancer in Diverse Populations

   • James Bailey
   • Robert M. Van Haren

   ASO Perspectives 12 June 2022 Pages: 5347 - 5349

4. Evaluating and Embracing Modern Imaging Technology to Guide Sentinel Node Biopsy for Melanoma

   • Marc D. Moncrieff
   • John F. Thompson

   Melanoma 01 June 2022 Pages: 5350 - 5352

5. I’ve Got Bad News and Bad News: The Cost of Colorectal Cancer Care

   • Alexander T. Hawkins

   Colorectal Cancer 13 July 2022 Pages: 5353 - 5354

6. Can We Predict Surgical Futility/Cure in Gallbladder Cancer?

   • Travis Grotz

   Hepatobiliary Tumors 07 June 2022 Pages: 5355 - 5356

7. Another Signal from DEBIRI

   • Michael C. Soulen
   • Sarah B. White

   Hepatobiliary Tumors 12 June 2022 Pages: 5357 - 5358

8. Should We Completely Exclude Locoregional Therapy for the Primary Tumor from Our Clinical Practice in De Novo Metastatic Breast Cancer?

   • Tulay Kus
   • Gokmen Aktas

   Breast Oncology 04 June 2022 Pages: 5359 - 5360

9. Editorial Comment on: One-Year Experience of Same-Day Mastectomy and Breast Reconstruction Protocol

   • Leah S. Kim
   • Tristen Park
   • Rachel A. Greenup

   Breast Oncology 14 July 2022 Pages: 5361 - 5363

10. Commentary on “Differences in the Clinicopathologic Behavior of Oncocytic Adrenocortical Neoplasms and Conventional Adrenocortical Carcinomas” by Shirali et al.

    • Colleen M. Kiernan
    • Carmen C. Solorzano

    Endocrine Tumors 24 April 2022 Pages: 5364 - 5366

11. Defining Relevancy in Patient-Reported Outcomes for Lung Cancer Surgery

    • Andrew P. Dhanasopon
    • Daniel J. Boffa

    Thoracic Oncology 03 May 2022 Pages: 5367 - 5368

12. Improving Oncologic Outcomes for Esophageal Cancer After Open and Minimally Invasive Esophagectomy

    • Alexandra I. Mansour
    • Rishindra M. Reddy

    Thoracic Oncology 02 July 2022 Pages: 5369 - 5371

13. The WASH (Water or Saline at High Volumes) Trial: A Randomized Trial to Assess the Survival Impact of Extensive Peritoneal Lavage Using Distilled Water or Saline at High Volumes After Pancreatic Resection for Pancreatic Ductal Adenocarcinoma

    • Areeba Saif
    • Martha Teke
    • Harish Lavu

    ASO Research Letter 04 June 2022 Pages: 5372 - 5374

    

14. A Randomized Study of Olaparib or Placebo in Patients with Surgically Removed Pancreatic Cancer who have a BRCA1, BRCA2 or PALB2 Mutation (The APOLLO Trial)

    • Martha E. Teke
    • Areeba Saif
    • Kim A. Reiss

    ASO Research Letter 06 June 2022 Pages: 5375 - 5376

    

15. The Impact of COVID-19-Related Delays on Surgical Management of Peritoneal Surface Malignancies

    • Divya Sood
    • Ankit Dhiman
    • Oliver S. Eng

    ASO Research Letter 03 May 2022 Pages: 5377 - 5378

    

16. Is the Choosing Wisely Recommendation for Omission of Sentinel Lymph Node Biopsy Applicable for Invasive Lobular Carcinoma?

    • Neil Carleton
    • Steffi Oesterreich
    • Priscilla F. McAuliffe

    ASO Research Letter 13 June 2022 Pages: 5379 - 5382

    

17. Inflammatory Breast Cancer: Durable Breast Cancer-Specific Survival for HER2-Positive Patients with a Pathologic Complete Response to Neoadjuvant Therapy

    • Tina J. Hieken
    • Judy C. Boughey
    • Tanya L. Hoskin

    ASO Research Letter 30 June 2022 Pages: 5383 - 5386

    

18. Financial Impact of Out-of-Pocket Costs Among Patients Undergoing Resection for Colorectal Carcinoma

    • Alessandro Paro
    • J. Madison Hyer
    • Timothy M. Pawlik

    Global Health Services Research 16 April 2022 Pages: 5387 - 5397

    

19. ASO Author Reflections: The Financial Impact of Out-of-Pocket Costs Among Patients Undergoing Resection for Colorectal Carcinoma

    • Alessandro Paro
    • Timothy M. Pawlik

    ASO Author Reflections 12 April 2022 Pages: 5398 - 5399

20. ASO Visual Abstract: The Financial Impact of Out-of-Pocket Costs Among Patients Undergoing Resection for Colorectal Carcinoma

    • Alessandro Paro
    • J. Madison Hyer
    • Timothy M. Pawlik

    ASO Visual Abstract 17 May 2022 Pages: 5400 - 5400

21. The Pivotal Leadership of Doctors R. Lee Clark and Murray M. Copeland in Transforming the Commission on Cancer (1955–1965)

    • Charles M. Balch
    • David P. Winchester
    • Edward M. Copeland

    Global Health Services Research 04 June 2022 Pages: 5401 - 5421

    

22. Patterns and Impact of Fragmented Care in Stage II and III Gastric Cancer

    • Kristen E. Rhodin
    • Vignesh Raman
    • Dan G. Blazer

    Global Health Services Research 20 June 2022 Pages: 5422 - 5431

    

23. ASO Author Reflections: Care Fragmentation in an Era of Centralization

    • Kristen E. Rhodin
    • Daniel P. Nussbaum
    • Dan G. Blazer 3rd

    ASO Author Reflections 28 June 2022 Pages: 5432 - 5433

24. ASO Visual Abstract: Patterns and Impact of Fragmented Care in Stages II and III Gastric Cancer

    • Kristen E. Rhodin
    • Vignesh Raman
    • Dan G. Blazer III

    ASO Visual Abstract 09 July 2022 Pages: 5434 - 5435

25. Correction to: Data-Driven Respectful Discourse in the Society of Surgical Oncology

    • Camille L. Stewart
    • Susanne G. Warner
    • Martin Heslin

    Correction 13 March 2022 Pages: 5436 - 5436

26. Postmastectomy Breast Reconstruction Patterns at an Urban Academic Hospital and the Impact of Surgeon Gender

    • Genevieve Fasano
    • Solange Bayard
    • Vivian J. Bea

    Reconstructive Oncology 18 May 2022 Pages: 5437 - 5444

    

27. ASO Visual Abstract: Postmastectomy Breast Reconstruction Patterns at an Urban Academic Hospital and the Impact of Surgeon Gender

    • Genevieve Fasano
    • Solange Bayard
    • Vivian J. Bea

    ASO Visual Abstract 05 June 2022 Pages: 5445 - 5446

28. Early Recurrence in Resected Gallbladder Carcinoma: Clinical Impact and Its Preoperative Predictive Score

    • Yuji Shimizu
    • Ryo Ashida
    • Katsuhiko Uesaka

    Hepatobiliary Tumors 06 June 2022 Pages: 5447 - 5457

    

29. ASO Author Reflections: Preoperative Prediction Score for Early Recurrence of Resected Gallbladder Carcinoma and Consideration of Optimal Treatment Strategies

    • Yuji Shimizu
    • Ryo Ashida
    • Katsuhiko Uesaka

    ASO Author Reflections 01 June 2022 Pages: 5458 - 5459

30. ASO Visual Abstract: Early Recurrence in Resected Gallbladder Carcinoma-Clinical Impact and Its Preoperative Predictive Score

    • Yuji Shimizu
    • Ryo Ashida
    • Katsuhiko Uesaka

    ASO Visual Abstract 07 July 2022 Pages: 5460 - 5461

31. Drug-Eluting Bead, Irinotecan Therapy of Unresectable Intrahepatic Cholangiocarcinoma (DELTIC) with Concomitant Systemic Gemcitabine and Cisplatin

    • Robert C. G. Martin II
    • Kerri A. Simo
    • Charles R. Scoggins

    Hepatobiliary Tumors 03 June 2022 Pages: 5462 - 5473

    

32. ASO Visual Abstract: Drug-Eluting Beads with Irinotecan Therapy of Unresectable Intrahepatic Cholangiocarcinoma (DELTIC) with Concomitant Systemic Gemcitabine and Cisplatin

    • Robert C. G. Martin II
    • Kerri A. Simo
    • Charles R. Scoggins

    ASO Visual Abstract 12 July 2022 Pages: 5474 - 5475

33. Increased Morbidity and Mortality After Hepatectomy for Colorectal Liver Metastases in Frail Patients is Largely Driven by Worse Outcomes After Minor Hepatectomy: It’s Not “Just a Wedge”

    • Natasha Leigh
    • Gregory A. Williams
    • Dominic E. Sanford

    Hepatobiliary Tumors 20 May 2022 Pages: 5476 - 5485

    

34. ASO Visual Abstract: Increased Morbidity and Mortality After Hepatectomy for Colorectal Liver Metastases in Frail Patients is Largely Driven by Worse Outcomes After Minor Hepatectomy: It is Not “Just a Wedge”

    • Natasha Leigh
    • Gregory A. Williams
    • Dominic E. Sanford

    ASO Visual Abstract 09 May 2022 Pages: 5486 - 5487

35. Trends and Disparities in Treatment Utilization for Early-Stage Hepatocellular Carcinoma in the Veteran Population

    • Patricio M. Polanco
    • Michelle R. Ju
    • Adam C. Yopp

    Hepatobiliary Tumors 22 May 2022 Pages: 5488 - 5497

    

36. ASO Author Reflections: Disparities in Utilization of Curative-Intent Therapy for Veterans with Early-Stage HCC

    • Michelle R. Ju
    • Patricio M. Polanco

    ASO Author Reflections 03 June 2022 Pages: 5498 - 5499

37. ASO Visual Abstract: Trends and Disparities in Treatment Utilization for Early-Stage Hepatocellular Carcinoma in the Veteran Population

    • Patricio M. Polanco
    • Michelle R. Ju
    • Adam C. Yopp

    ASO Visual Abstract 04 June 2022 Pages: 5500 - 5501

38. Preoperative Diagnosis of Lymph Node Metastasis of Perihilar Cholangiocarcinoma Using Diffusion-Weighted Magnetic Resonance Imaging

    • Isamu Hosokawa
    • Koichi Hayano
    • Masayuki Ohtsuka

    Hepatobiliary Tumors 31 May 2022 Pages: 5502 - 5510

    

39. ASO Author Reflections: Importance of Preoperative Diagnosis of Lymph Node Metastasis in Perihilar Cholangiocarcinoma

    • Isamu Hosokawa
    • Kentaro Togasaki
    • Masayuki Ohtsuka

    ASO Author Reflections 27 May 2022 Pages: 5511 - 5512

40. ASO Visual Abstract: Preoperative Diagnosis of Lymph Node Metastasis of Perihilar Cholangiocarcinoma Using Diffusion-Weighted Magnetic Resonance Imaging

    • Isamu Hosokawa
    • Masayuki Ohtsuka

    ASO Visual Abstract 30 June 2022 Pages: 5513 - 5514

41. The Histopathological Growth Pattern of Colorectal Liver Metastases Impacts Local Recurrence Risk and the Adequate Width of the Surgical Margin

    • L. Viganò
    • B. Branciforte
    • G. Torzilli

    Hepatobiliary Tumors 10 June 2022 Pages: 5515 - 5524

    

42. ASO Author Reflections: The Histopathological Growth Pattern of Colorectal Liver Metastases: A New Biomarker to Drive Surgical Strategy

    • L. Viganò
    • B. Branciforte
    • G. Torzilli

    ASO Author Reflections 03 May 2022 Pages: 5525 - 5526

43. ASO Visual Abstract: The Histopathological Growth Pattern of Colorectal Liver Metastases Impacts Local Recurrence Risk and the Adequate Width of the Surgical Margin

    • L. Viganò
    • B. Branciforte
    • G. Torzilli

    ASO Visual Abstract 31 May 2022 Pages: 5527 - 5527

44. Hepatic Arterial Infusion Pump Chemotherapy for Unresectable Intrahepatic Cholangiocarcinoma: A Systematic Review and Meta-Analysis

    • Jessica J. Holster
    • Marouan El Hassnaoui
    • Bas Groot Koerkamp

    Hepatobiliary Tumors Open access 16 March 2022 Pages: 5528 - 5538

    

45. ASO Author Reflections: Usage of Hepatic Arterial Infusion Pump Chemotherapy for Unresectable Intrahepatic Cholangiocarcinoma

    • Jessica J. Holster
    • Bas Groot Koerkamp

    ASO Author Reflections Open access 09 March 2022 Pages: 5539 - 5540

46. ASO Visual Abstract: Hepatic Arterial Infusion Pump Chemotherapy for Unresectable Intrahepatic Cholangiocarcinoma—A Systematic Review and Meta-analysis

    • Jessica J. Holster
    • Marouan El Hassnaoui
    • Bas Groot Koerkamp

    ASO Visual Abstract 14 March 2022 Pages: 5541 - 5542

47. Full Laparoscopic Vascular Reconstruction for Portal Tumoral Invasion During a Right Hepatectomy Using the Caudal Approach

    • Fernando Rotellar
    • Juan Luján
    • Gabriel Zozaya

    Hepatobiliary Tumors Open access 04 June 2022 Pages: 5543 - 5544

48. ASO Author Reflections: A New Red Line Trespassed? Vascular Resection and Reconstruction No Longer a Contraindication for Minimally Invasive Liver Surgery

    • Fernando Rotellar
    • Pablo Martí-Cruchaga
    • Gabriel Zozaya

    ASO Author Reflections 06 June 2022 Pages: 5545 - 5546

49. ASO Visual Abstract: Full Laparoscopic Vascular Reconstruction for Portal Tumoral Invasion During Right Hepatectomy Using the Caudal Approach

    • Fernando Rotellar
    • Juan Luján
    • Gabriel Zozaya

    ASO Visual Abstract 27 May 2022 Pages: 5547 - 5547

50. Laparoscopic Orthotopic Right Hemihepatectomy by Anterior Approach Combined with Inferior Vena Cava Thrombectomy

    • Jiaqi Gao
    • Junhao Zheng
    • Xiao Liang

    Hepatobiliary Tumors 04 May 2022 Pages: 5548 - 5549